Efficacy and palatability of the developed polyethylene glycol-based formula for the treatment of children with functional constipation

Table 1 Patient demographics and baseline characteristics (n = 52)

Variables	PEG-Chula(n = 26)	Commercial PEG(n = 26)
Age (years)	4.38 (2.90, 7.00)	3.92 (2.25, 9.91)
Age group (6 months-4 years)	11 (42.30)	14 (53.80)
Sex, males	11 (42.30)	6 (23.10)
Weight (kg)	16.1 (12.20, 25.20)	15.3 (11.50, 30.10)
Height (cm)	101 (90.00, 124.50)	97.75 (84.50, 135.00)
FC in family	15 (57.70)	16 (61.54)
Previous treatment for FC	14 (53.90)	11 (42.30)
Duration of constipation (months)	21 (12, 48)	16.5 (12, 30)
Frequency of defecation (time/week)	1.96 ± 0.58	2.21 ± 0.74
Stool consistency (Bristol Stool scale)	2.31 ± 0.78	2.08 ± 0.82
Painful defecation (Facial Pain scale)	3.65 ± 1.16	3.48 ± 1.01
Clogged toilet for toilet-trained children (n = 42)	13 (59.09)	10 (50.00)
Presence of fecal mass by examination	2 (7.69)	1 (3.85)
Blood coating the stool	11 (42.31)	8 (30.77)
Anal position index
Male	0.51 ± 0.06	0.5 ± 0.05
Female	0.38 ± 0.09	0.37 ± 0.06

Data were presented by mean ± SD, median (interquartile range) or n (%). FC: Functional constipation; PEG: Polyethylene glycol.